The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword

Michael Hölzel; Kaspar Burger; Bastian Mühl; Mathias Orban; Markus Kellner; Dirk Eick

doi:10.18632/oncotarget.107

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Perspectives:

The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword

Michael Hölzel, Kaspar Burger, Bastian Mühl, Mathias Orban, Markus Kellner and Dirk Eick _

PDF | How to cite

Oncotarget. 2010; 1:43-47. https://doi.org/10.18632/oncotarget.107

Metrics: PDF 3746 views | ?

Abstract

Received: February 23, 2010, Accepted: April 18, 2010, Published: May 1, 2010

Since its first description more than 30 years ago p53 has become a paradigm for a protein with versatile functions. P53 sensitizes a large variety of genetic alterations and has been entitled the guardian of the genome. Stabilization of p53 upon DNA damage is accompanied by a complex pattern of modifications, which ascertain the cellular response either in the direction of a reversible or irreversible cell cycle arrest or programmed cell death. More recently it became evident that p53 also responds to non-genotoxic cell stress, in particular if ribosome biogenesis is affected.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 107

Publication Alerts

Research Perspectives:

The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword

Abstract